A Phase III Clinical Trial to Evaluate the Protective Efficacy of Three Doses of Oral Rotavirus Vaccine (ORV) 116E

NCT01305109 · clinicaltrials.gov ↗

PHASE3

Phase

UNKNOWN

Status

6800

Enrollment

INDUSTRY

Sponsor class

Conditions

Viral Gastroenteritis Due to Rotavirus

Interventions

BIOLOGICAL: ORV 116E
BIOLOGICAL: Placebo

Sponsor

Bharat Biotech International Limited

Collaborators

[object Object]
[object Object]